for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-Innovent Biologics Says NMPA Granted Marketing Approval For Byvasda (Bevacizumab Biosimilar) In China

June 19 (Reuters) - Innovent Biologics Inc:

* INNOVENT BIOLOGICS INC- NMPA GRANTED MARKETING APPROVAL FOR BYVASDA (BEVACIZUMAB BIOSIMILAR) IN CHINA Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up